Theriva Biologics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
5.50
|
|
Average Rating
|
5.00
|
|
# Strong Buys
|
1
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.39
|
-0.33
|
0.06
|
15.38%
|
|
2022-06-30
|
-0.35
|
-0.31
|
0.04
|
11.43%
|
|
2022-03-31
|
-0.30
|
-0.30
|
0.00
|
0.00%
|
|
2021-12-31
|
-0.30
|
-0.40
|
-0.10
|
-33.33%
|
|
2021-09-30
|
-0.25
|
-0.20
|
0.05
|
20.00%
|
|
2021-06-30
|
-0.20
|
-0.20
|
0.00
|
0.00%
|
|
2021-03-31
|
-0.20
|
-1.30
|
-1.10
|
-550.00%
|
|
2020-12-31
|
-0.80
|
-1.40
|
-0.60
|
-75.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.94
|
|
2021-12-31
|
-2.10
|
|
2020-12-31
|
-4.80
|
|
2019-12-31
|
-0.93
|
|
2018-12-31
|
-3.00
|
|
2017-12-31
|
-5.95
|
|
2016-12-31
|
-4.03
|
|
2015-12-31
|
-0.56
|
|
2014-12-31
|
-52.67
|
|
2013-12-31
|
-252.71
|
|
2011-12-31
|
-113.56
|
|
2009-12-31
|
-61.64
|
|
2008-12-31
|
-122.14
|
|
2007-12-31
|
-472.05
|
|
2006-12-31
|
-317.90
|
|
2005-12-31
|
-22.23
|
|
2004-12-31
|
-272042.73
|
|
1996-12-31
|
-199.50
|